tiprankstipranks
Trending News
More News >
Innate Pharma S.A. (IPHYF)
:IPHYF
US Market

Innate Pharma SA (IPHYF) Technical Analysis

Compare
27 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
1Neutral
8Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
5Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Innate Pharma S.A.’s (IPHYF) Moving Averages Convergence Divergence (MACD) indicator is 0.11, suggesting Innate Pharma S.A. is a Sell.
Innate Pharma S.A.’s (IPHYF) 20-Day exponential moving average is 1.79, while Innate Pharma S.A.’s (IPHYF) share price is $1.95, making it a Buy.
Innate Pharma S.A.’s (IPHYF) 50-Day exponential moving average is 1.76, while Innate Pharma S.A.’s (IPHYF) share price is $1.95, making it a Buy.

Innate Pharma SA (IPHYF) Pivot Points

Jul 07, 2025, 01:34 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.95
1.95
1.95
1.95
1.95
1.95
1.95
Fibonacci
1.95
1.95
1.95
1.95
1.95
1.95
1.95
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Innate Pharma SA (IPHYF) Moving Averages

Jul 07, 2025, 01:34 AM
Period
Simple
Exponential
MA5
1.95Buy
1.94Buy
MA10
1.91Buy
1.89Buy
MA20
1.75Buy
1.79Buy
MA50
1.57Buy
1.76Buy
MA100
2.09Sell
1.93Buy
MA200
2.14Sell
2.03Sell
Innate Pharma S.A.’s (IPHYF) 10-Day exponential moving average is 1.89, while Innate Pharma S.A.’s (IPHYF) share price is $1.95, making it a Buy.
Innate Pharma S.A.’s (IPHYF) 100-Day exponential moving average is 1.93, while Innate Pharma S.A.’s (IPHYF) share price is $1.95, making it a Buy.
Innate Pharma S.A.’s (IPHYF) stock price is $1.95 and Innate Pharma S.A.’s (IPHYF) 50-day simple moving average is 1.57, creating a Buy signal.
Innate Pharma S.A.’s (IPHYF) stock price is $1.95 and Innate Pharma S.A.’s (IPHYF) 100-day simple moving average is 2.09, creating a Sell signal.
Innate Pharma S.A.’s (IPHYF) stock price is $1.95 and Innate Pharma S.A.’s (IPHYF) 200-day simple moving average is 2.14, creating a Sell signal.

Innate Pharma SA (IPHYF) Technical Indicators

Jul 07, 2025, 01:34 AM
Name
Value
Implied Action
RSI (14)
92.58
Sell
STOCH (9,6)
100.00
Sell
STOCHRSI (14)
100.00
Sell
MACD (12,26)
0.11
Sell
ADX (14)
92.54
Sell
Williams %R
0.00
Sell
CCI (14)
83.33
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
111.56
Buy
ROC
12.07
Buy
Innate Pharma S.A.’s (IPHYF) Relative Strength Index (RSI) is 92.58, creating a Sell signal.
Innate Pharma S.A.’s (IPHYF) Trend Strength Indicator (ADX) is 92.54, creating a Sell signal.
Innate Pharma S.A.’s (IPHYF) Commodity Channel Index (CCI) is 83.33, creating a Neutral signal.
Innate Pharma S.A.’s (IPHYF) Price Rate of Change (ROC) is 12.07, creating a Buy signal.

FAQ

Is IPHYF a Buy, Hold, or Sell?
Based on IPHYF’s technical indicators, IPHYF is a Buy.
    What is IPHYF’s RSI (14)?
    IPHYF’s RSI (14) is 92.58, which suggests IPHYF is a Sell.
      What is IPHYF’s MACD?
      IPHYF’s MACD is 0.11, which suggests IPHYF is a Sell.
        What is IPHYF’s 5-day moving average?
        IPHYF’s 5-day moving average is 1.95, which suggests IPHYF is a Buy.
          What is IPHYF’s 20-day moving average?
          IPHYF 20-day moving average is 1.75, which suggests IPHYF is a Buy.
            What is IPHYF’s 50-day moving average?
            IPHYF’s 50-day moving average is 1.57, which suggests IPHYF is a Buy.
              What is IPHYF’s 200-day moving average?
              IPHYF’s 200-day moving average is 2.14, which suggests IPHYF is a Sell.
                What is IPHYF’s Williams % R (14)?
                IPHYF’s Williams % R (14) is 0.00, which suggests IPHYF is a Sell.
                  What is IPHYF’s CCI (14)?
                  IPHYF’s CCI (14) is 83.33, which suggests IPHYF is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis